GI Radiology > Small Bowel > Inflammatory Diseases > Crohn's Disease
Inflammatory diseases
Crohn’s Disease |
RadiologyFluoroscopy is the study
of choice for evaluation of luminal contour and mucosal integrity of the
small bowel. Fluoroscopic findings in Crohn’s disease can be divided into two
stages, early and late. Early findings represent active inflammation, while
late findings represent chronic inflammation and/or fibrosis. Early fluoroscopic
findings include: Mucosal ulcers (punctate collections of barium surrounded by
radiolucent mounds of edema) are best demonstrated on double contrast studies Luminal narrowing from edema, spasm Fold thickening or “thumbprinting” Late/chronic fluoroscopic
findings include: Deeper, larger, linear ulcers (most frequently in
terminal ileum) Strictures, manifest by the “string sign” CT augments fluoroscopy by
assessing for bowel wall and extraintestinal involvement, as well as allowing
for therapeutic percutaneous drainage of abscesses. CT will demonstrate
transmural spread of inflammation, with findings such as bowel wall
thickening, mesenteric stranding, adenopathy, and abscesses. CT also helps
evaluate for malignancy. Plain films are most often
acquired in the acute setting to evaluate for obstruction or free air. They
may identify extraintestinal abnormalities, such as nephrolithiasis or
sacroileitis. Ultrasound is an
alternative to CT for patients that cannot tolerate contrast material.
Sonographically , the normal intestinal wall is comprised of 5 concentric
layers, alternating between echogenic and hypoechoic (“gut signature”).
Sonographic findings in Crohn’s disease entail the distortion or destruction
of these layers. Similar to CT,
ultrasound can also detect extraintestinal manifestations, such as abscesses.
Real-time imaging allows for the evaluation of gut peristalsis, and Doppler
imaging often demonstrates increased blood flow associated with active
inflammation. Nuclear medicine is also used on occasion to
evaluate Crohn’s disease. Tagged WBC scans (technetium-99m-HMPAO, indium-111)
can assess for active inflammation. |